OQROGet OQRO Pro
Insider trade

Pfizer (PFE)SVP & Controller sold ~$51K

Jennifer B. Damico, SVP & Controller at Pfizer, sold ~$51K of Pfizer shares.

~$51K
Approx. value · 2,000 sh @ $25.70
31K
Holds after · shares reported
Traded
Jun 9, 2026
Filed
Jun 10, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 26, 2024CongressDisclosed sale of PFE — reported range $1,001 - $15,000
  2. Mar 10, 2025CongressDisclosed sale of PFE — reported range $15,001 - $50,000
  3. Mar 24, 2026CongressDisclosed sale of PFE — reported range $50,001 - $100,000
  4. Apr 23, 2026Federal contract · $2K obligatedDepartment of Defense awarded Pfizer: $2.2K obligated to date
  5. Apr 23, 2026Federal contract · $23K obligatedDepartment of Defense awarded Pfizer: $23K obligated to date
  6. May 1, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  7. May 5, 2026Company filing · Form 8-K · ResultsReported its results
  8. May 13, 2026Federal contract · $25K obligatedDepartment of Defense awarded Pfizer: $25K obligated to date
  9. May 15, 2026Federal contract · $543K obligatedDepartment of Health and Human Services awarded Pfizer: $543K obligated to date
  10. May 20, 2026Federal contract · $2K obligatedDepartment of Defense awarded Pfizer: $2.2K obligated to date
  11. Jun 5, 2026FDAFDA drug approval: Hympavzi
  12. Jun 8, 2026Government · Federal Register noticeDetermination That Protamine Sulfate (Protamine Sulfate) Intravenous; Solution, 50 Milligrams/5 Milliliters, and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
  13. Jun 8, 2026CongressDisclosed sale of PFE — reported range $15,001 - $50,000
  14. Jun 9, 2026 · this disclosureInsiderOfficer sold ~$51K of PFE shares in the open market

What came next

  1. Jun 18, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On June 16, 2026, Dave Denton notified Pfizer Inc. (the “Company”) that he will step down from his current position as Chief Financial Officer effective August 15, 2026 for a professional opportunity outside of the pharmaceutical industry in consumer goods, and that his departure is not related to the Company’s financial or operating results or to any disagreements with the Company regarding the Company’s financial,…”
  2. Jun 24, 2026FDAFDA drug approval: Ibrance
  3. Jun 24, 2026FDAFDA drug approval: Ibrance
  4. Jul 6, 2026Government · Federal Register noticeEndo Operations Limited, et al.; Withdrawal of Approval of 34 New Drug Applications
  5. Jul 20, 2026Government · Federal Register noticeForeign-Trade Zone (FTZ) 43, Notification of Proposed Production Activity; Pfizer Inc.; (Pharmaceutical Products); Kalamazoo and Portage, Michigan
  6. Aug 4, 2026Company filing · Form 8-K · ResultsReported its results
  7. Aug 5, 2026Insider · 3 peopleInsiders: 2 purchases (~$2.0M), 1 sale (~$83K)
  8. Aug 12, 2026Insider · Their first buy on recordCEO purchased ~$1M of PFE shares in the open market
  9. Aug 21, 2026Government · Federal Register noticeAdvisory Committee; Oncologic Drugs Advisory Committee; Renewal
  10. Sep 4, 2026FDARecall: Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC…
  11. Sep 25, 2026Government · Federal Register noticeJeffrey Thies: Final Debarment Order
  12. Oct 7, 2026FDAFDA drug approval: Tukysa
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Pfizer

For Pfizer, OQRO holds 4 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 54 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PFE page.

Other recent filings by Jennifer B. Damico, SVP & Controller

The full history of Jennifer B. Damico, SVP & Controller is on the profile page.

How this filing works

Other disclosures at Pfizer

Everything OQRO holds on this company is on its PFE page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data